Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_assertion type Assertion NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_head.
- NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_assertion description "[To determine whether this strategy could be used to kill tumor cells without host toxicity, nude mice bearing human malignant D54MG glioma tumors expressing E. coli PNP (D54-PNP) were treated with either 6-methylpurine-2'-deoxyriboside (MeP-dR) or arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP, fludarabine, a precursor of F-araA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_provenance.
- NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_assertion evidence source_evidence_literature NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_provenance.
- NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_assertion SIO_000772 9322865 NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_provenance.
- NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_assertion wasDerivedFrom befree-20140225 NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_provenance.
- NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_assertion wasGeneratedBy ECO_0000203 NP694170.RAOiYVXGkRz4_kqmz5GOpHd53Z0hkG_HrMndrc7rLXbcQ130_provenance.